Gelonghui December 3rd - Hongyuan Pharmaceutical (301246.SZ) announced that as of November 30, 2024, the company has repurchased a total of 2,020,200 shares of the company through a repurchase special securities account in a centralized competitive trading manner, accounting for 0.51% of the company's current total share capital. The highest fill price was 17.92 yuan/share, the lowest fill price was 12.25 yuan/share, and the total trading amount was RMB 31.4017 million yuan (excluding trading fees).
- Headlines
- Hongyuan Pharmaceutical (301246.SZ): has repurchased 0.51% of the shares accumulated.
宏源药业(301246.SZ)：已累计回购0.51%股份
Hongyuan Pharmaceutical (301246.SZ): has repurchased 0.51% of the shares accumulated.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Write a comment
0 0 0
LikeLoveLaughing CryRespectEmmSadAngry
Tap to Select a Mood
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
Use the share button in your browser
to share the page with your friends
Tap here to share
No comments yet. Write one.
Related Stocks Related Stocks
Statement
This page is machine-translated. Futubull tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation.